Stock Screener App

Frei -

Installieren

24.64

4.01% 0.95

Avalyn Pharma Inc (AVLN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Avalyn Pharma Inc-Aktie (AVLN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
Operating Expenses	12.11% 31.29	27.91
Operating Income/Loss	12.11% -31.29	-27.91
Nonoperating Income/Loss	126.44% 2.355	1.04
Income Tax Expense/Benefit	-	-
Net Income/Loss	7.69% -28.93	-26.87
Basic Average Shares	2,309% 29.65	1.2307
Diluted Average Shares	2,309% 29.65	1.2307
Basic Earnings Per Share	95.51% -0.98	-21.83
Diluted Earnings Per Share	95.51% -0.98	-21.83

IMTX

$7.14

2.00%

REPL

$11.75

3.16%

JANX

$17.32

1.11%

MRVI

$7.07

7.94%

NBTX

$22.23

4.46%

VOR

$19.34

3.15%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters